Literature DB >> 6601689

Lymphocyte capping in myotonic dystrophy.

G L Walker, U Karagol, E C Mathieson, R J Lane, F L Mastaglia.   

Abstract

Lymphocyte capping with antihuman immunoglobulin was studied in 16 cases of myotonic dystrophy, including two cases with the congenital form. Percentage capping after 1 hour incubation was reduced and the time course of the capping sequence was apparently delayed. The significance of these findings remains to be determined.

Entities:  

Mesh：

Year:  1983        PMID： 6601689      PMCID： PMC1027272          DOI： 10.1136/jnnp.46.1.90

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  17 in total

1.  Lymphocyte capping in muscular dystrophy.

Authors:  S L Hauser; H L Weiner; M J Bresnan; K A Ault
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

2.  Abnormal leukocyte electrophoretic mobility in myotonic dystrophy.

Authors:  A R Seay; F A Ziter; H R Hill
Journal:  J Neurol Sci       Date:  1979-12       Impact factor: 3.181

3.  Systemic membrane defect in the proximal muscular dystrophies.

Authors:  N A Pickard; H D Gruemer; H L Verrill; E R Isaacs; M Robinow; W E Nance; E C Myers; B Goldsmith
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  Lymphocyte capping in Duchenne muscular dystrophy.

Authors:  C M Stern; M C Kahan; V Dubowitz
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

5.  Vascular adrenergic receptor responses in skeletal muscle in myotonic dystrophy.

Authors:  F Mechler; F L Mastaglia
Journal:  Ann Neurol       Date:  1981-02       Impact factor: 10.422

6.  Human lymphocyte capping in Duchenne muscular dystrophy.

Authors:  A L Horenstein; A E Emery
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

7.  The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.

Authors:  B M Goldsmith; H D Gruemer; R J Hawley; N A Pickard; H L Verrill; W E Nance; G Miller; R G Crawford
Journal:  Clin Chem       Date:  1980-05       Impact factor: 8.327

8.  Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy.

Authors:  A D Ho; S Stojakowits; B Reitter; W Fiehn; G Zipperle; W Hunstein; C Lipinski
Journal:  Klin Wochenschr       Date:  1980-04-01

9.  Immunologic derangement in myotonic dystrophy--abnormal contact sensitization to dinitrochlorobenzene.

Authors:  Y Kuroiwa; H Sugita; Y Toyokura; M Mizoguchi; H Matsuo; Y Nonaka
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181

10.  Evaluation of insulin receptor in myotonic dystrophy.

Authors:  B W Festoff; W V Moore
Journal:  Ann Neurol       Date:  1979-07       Impact factor: 10.422
View more
  1 in total

1.  Nifedipine in the treatment of myotonia in myotonic dystrophy.

Authors:  R Grant; D L Sutton; P O Behan; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.